We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+9.66%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$89.3B
AUM Growth
+$8.23B
Cap. Flow
+$1.9B
Cap. Flow %
2.12%
Top 10 Hldgs %
24.87%
Holding
4,460
New
1,490
Increased
1,679
Reduced
1,235
Closed
38

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$60.1M
2
TSM icon
TSMC
TSM
+$59.1M
3
TSLA icon
Tesla
TSLA
+$56M
4
AAPL icon
Apple
AAPL
+$55.2M
5
AMZN icon
Amazon
AMZN
+$47.5M

Top Sells

Rank Stock Value
1
ACWX icon
iShares MSCI ACWI ex US ETF
ACWX
+$102M
2
EG icon
Everest Group
EG
+$27.4M
3
CVX icon
Chevron
CVX
+$25M
4
WFC icon
Wells Fargo
WFC
+$24.9M
5
CXT icon
Crane NXT
CXT
+$13.5M

Sector Composition

Rank Sector Weight
1 Technology 27.27%
2 Healthcare 12.98%
3 Financials 12.17%
4 Consumer Discretionary 11.18%
5 Industrials 9.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBT
3151
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
$164K ﹤0.01%
30,035
+2,076
+7% +$10.9K
NKSH icon
3152
National Bankshares
NKSH
$268M
$164K ﹤0.01%
+5,621
New +$168K
UONEK icon
3153
Urban One Class D
UONEK
$23.8M
$164K ﹤0.01%
2,727
-55
-2% -$3.12K
PKOH icon
3154
Park-Ohio Holdings
PKOH
$761M
$164K ﹤0.01%
+8,608
New +$131K
CDZI icon
3155
Cadiz
CDZI
$291M
$163K ﹤0.01%
+40,150
New +$177K
B
3156
Barrick Mining
B
$73.2B
$163K ﹤0.01%
+9,611
New +$175K
PSTX
3157
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$162K ﹤0.01%
+92,161
New +$235K
FEAM icon
3158
5E Advanced Materials
FEAM
$62.3M
$162K ﹤0.01%
2,149
-3
-0.1% -$285
CIGI icon
3159
Colliers International
CIGI
$5.19B
$162K ﹤0.01%
+1,648
New +$160K
ASMI
3160
DELISTED
ASM INTERNATL N.V
ASMI
$161K ﹤0.01%
+379
New +$161K
WHWK
3161
Whitehawk Therapeutics
WHWK
$271M
$161K ﹤0.01%
23,548
+4,245
+22% +$33K
EVBN
3162
DELISTED
Evans Bancorp Inc
EVBN
$161K ﹤0.01%
+6,453
New +$175K
GENC icon
3163
Gencor Industries
GENC
$212M
$161K ﹤0.01%
+10,316
New +$148K
NGM
3164
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$161K ﹤0.01%
62,055
+6,363
+11% +$22.7K
ATLO icon
3165
AMES National
ATLO
$277M
$160K ﹤0.01%
+8,891
New +$167K
KLXE icon
3166
KLX Energy Services
KLXE
$42.3M
$160K ﹤0.01%
+16,468
New +$162K
RGCO icon
3167
RGC Resources
RGCO
$228M
$160K ﹤0.01%
+7,996
New +$165K
LCNB icon
3168
LCNB Corp
LCNB
$283M
$160K ﹤0.01%
+10,808
New +$165K
HRTX icon
3169
Heron Therapeutics
HRTX
$92.9M
$159K ﹤0.01%
137,418
+973
+0.7% +$1.74K
GORV
3170
DELISTED
Lazydays
GORV
$159K ﹤0.01%
+460
New +$158K
LSEA
3171
DELISTED
Landsea Homes
LSEA
$159K ﹤0.01%
17,019
+2,477
+17% +$17.3K
MEC icon
3172
Mayville Engineering Co
MEC
$617M
$159K ﹤0.01%
+12,750
New +$161K
CWBC
3173
Community West Bancshares
CWBC
$684M
$157K ﹤0.01%
+10,179
New +$158K
PHLT
3174
DELISTED
Performant Healthcare Inc
PHLT
$157K ﹤0.01%
+58,092
New +$168K
CRGE
3175
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
$157K ﹤0.01%
160,024
+3,500
+2% +$3.56K

Similar funds

RhumbLine Advisers's Q2 2023 Portfolio in Review

As of Q2 2023, RhumbLine Advisers held 4,460 positions worth $89.3B, up 10% from $81B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

RhumbLine Advisers's Q2 2023 filing shows 1,490 new, 1,679 increased, 1,235 reduced and 38 closed positions. Its largest new stake was TSMC: 635,517 shares worth $64.1M. The largest sale was iShares MSCI ACWI ex US ETF, an estimated $102M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

  • RhumbLine Advisers's largest Q2 2023 buy was TSMC: 635,517 shares worth $64.1M.
  • RhumbLine Advisers added most to Microsoft in Q2 2023, an estimated $60.1M increase.
  • RhumbLine Advisers's biggest Q2 2023 reduction was iShares MSCI ACWI ex US ETF, cutting an estimated $102M.
  • RhumbLine Advisers fully exited Everest Group in Q2 2023, selling an estimated $27.4M.
  • RhumbLine Advisers's ten largest holdings make up 25% of its $89.3B portfolio in Q2 2023.
  • RhumbLine Advisers opened 1,490 new positions and closed 38 in Q2 2023.
  • RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $89.3B.

Based on RhumbLine Advisers's 13F filing for Q2 2023, filed 8 Aug 2023.